Senti Biosciences's total assets for Q3 2025 were $52.69M, a decrease of -23.13% from the previous quarter. SNTI total liabilities were $44.56M for the fiscal quarter, a 1.54% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.